Group of biomedical engineers from biotech company Gruppo Fos Lithuania together with researchers at Kaunas University of Technology and Lithuanian University of Health Sciences have patented technology for advanced health monitoring of stroke survivors. It is the first solution in the world which monitors and analyses simultaneously a patient’s health parameters from the affected part of the brain and those of the cardiovascular system. Stroke is a sudden impairment of the cerebral circulation, resulting in the death of the brain…

Researchers at the University of Michigan have developed robotic prosthetic legs which use motors that were originally designed for use on the robotic arm of the International Space Station. The motors allow the prostheses to move more naturally, producing less stress on the hips of users, and they are also quieter and more energy efficient than pre-existing robotic legs. Conventional prosthetic legs require the wearer to move their hips abnormally to raise the foot and swing the leg forward. This…

The trials are being operated by health practitioners from SEHA who are providing facilities at five of their sites in Abu Dhabi and Al Ain in addition to a mobile clinic to ensure the trials are readily accessible to volunteers participating in the program The first WHO enlisted global clinical Phase III trial of Sinopharm CNBG’s inactivated vaccine to combat COVID-19 has started in Abu Dhabi and has been inspired by the UAE Leadership’s vision and commitment to overcome the…

Fluorescence spectroscopy is a non-destructive technique that is able to give rapid and sensitive results. The technique uses a light beam (usually ultraviolet) to excite electrons, thereby causing them to fluoresce. This light is then directed towards a filter and onto a detection mechanism where the molecule, or changes in it, can be measured and identified. This is measured by what is termed a fluorescence excitation spectrum The quality, safety, and authenticity of our food is of the utmost importance…

The global nuclear medicine market size was valued at $6.1 billion in 2019 and is estimated to witness a CAGR of 9.5% during the forecast period. Rising incidence of cancer is one of the major factors expected to boost the market for nuclear medicine. For instance, according to WHO, in 2018, globally there were an estimated 9.6 million deaths due to cancer According to the Center for Nuclear Science and Technology Information, about one-third of all procedures used in modern…